Publication

The following are some of the academic articles which have used MDV data.

Academic Articles

Total number of publications

789

Publication Icon

Search for Articles

The term "full-match search" refers to searching for items that contain all the words entered, while "partial-match search" refers to searching for items that contain even one of the words entered.

~

Search results: 56

Download Publication List

2025

TitleHypoglycemia-Related Hospitalization in Adults with Type 2 Diabetes Receiving Insulin in Japan: Real-World Analysis Using the Medical Data Vision Database
AuthorsTakeshi Miyatsuka, Maiko Kino, Elisabeth de Laguiche & Onkar Kakade
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleSemaglutide Adherence and Cardiovascular Diseases in Patients With Type 2 Diabetes: Evidence From Real-World Data in Japan
AuthorsChikako Masudo, Takeshi Horii, Ririka Suzuki, Kiyoshi Mihara
PublishedCureus
Therapeutic AreaType 2 diabetes
TitleRisk factors for nephropathy in individuals with new-onset type 2 diabetes undergoing treatment for hypertension: A retrospective analysis using the Diagnosis Procedure Combination database
AuthorsTomoko Ishigaki, Suzuki Mari, Saito Oba, Kohei Uemura
PublishedAnnals of Clinical Epidemiology
Therapeutic AreaType 2 diabetes
TitleSafety of iGlarLixi in Japanese People with Type 2 Diabetes: A Post-marketing Database Study
AuthorsHideaki Kaneto, Makiko Hatanaka, Yukiko Morimoto, Yoko Takahashi & Yasuo Terauchi
PublishedAdvances in Therapy
Therapeutic AreaType 2 diabetes

2024

TitleEffects of SGLT2 inhibitors on the onset of esophageal varices and extrahepatic cancer in type 2 diabetic patients with suspected MASLD: a nationwide database study in Japan
AuthorsTakumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, Fusayo Io, Yuri Sato, Saeko Uchida & Yukiko Kitajima
PublishedJournal of Gastroenterology
Therapeutic AreaType 2 diabetes
TitleAdherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data
AuthorsTakeshi Horii, Chikako Masudo, Yui Takayanagi, Yoichi Oikawa, Akira Shimada, Kiyoshi Mihara
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleFactor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan
AuthorsTakeshi Horii, Yoichi Oikawa, Kasumi Kidowaki, Akira Shimada, Kiyoshi Mihara
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleEarly Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform
AuthorsAtsuhisa Sato, Daloha Rodriguez-Molina, Kanae Yoshikawa-Ryan, Satoshi Yamashita, Suguru Okami, Fangfang Liu, Alfredo Farjat, Nikolaus G. Oberprieler, Csaba P. Kovesdy, Keizo Kanasaki and David Vizcaya
PublishedJournal of Clinical Medicine
Therapeutic AreaType 2 diabetes
TitleMedical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs
AuthorsRyo Suzuki, Kiyoyasu Kazumori, Tatsuya Usui, Masahiko Shinohara
PublishedJournal of Diabetes Inverstigation
Therapeutic AreaType 2 diabetes

2023

TitlePrescription patterns and therapeutic effects of second-line drugs in Japanese patients with type 2 diabetes mellitus: Analysis of claims data for metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycemic agents
AuthorsRimei Nishimura, Tomomi Takeshima, Kosuke Iwasaki & Sumiko Aoi
PublishedExpert Opinion on Pharmacotherapy
Therapeutic AreaType 2 diabetes
TitleRisk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: a large-scale medical receipt database analysis
AuthorsTakeshi Horii, Mai Otsuka, Takeo Yasu
PublishedBMJ Open Diabetes Research & Care
Therapeutic AreaType 2 diabetes
TitleProfile of People Initiating Oral Semaglutide for the Treatment of Type 2 Diabetes in Japan: Results of a Cross-Sectional Study Using a Large Nationwide Database
AuthorsKazushiro FUJIWARA, Niels Juul BROGAARD, Søren LOPHAVEN, Yuki NARITA, Satoshi TSUBOI
Published診療と新薬web
Therapeutic AreaType 2 diabetes
TitleReal-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in Japan
AuthorsTakeshi Horii, Yoichi Oikawa, Akira Shimada, Kiyoshi Mihara
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleComparison of the efficacy of anti-diabetic medications as add-on to metformin in type 2 diabetes mellitus from a real-world database
AuthorsRyosuke Ono, Chika Ogami, Chihiro Hasegawa, Hideto To, Yoshiaki Matsumoto & Yasuhiro Tsuji
PublishedBMC Pharmacology and Toxicology
Therapeutic AreaType 2 diabetes

2022

TitleManifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database
AuthorsTakashi Kadowaki, Issei Komuro, Naru Morita, Hiroki Akiyama, Yoko Kidani & Toshitaka Yajima
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleReduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: a real-world retrospective administrative database analysis in Japan
AuthorsAtsunori Kashiwagi, Shingo Shoji, Satoshi Onozawa, Yoshinori Kosakai, Miina Waratani, Yuichiro Ito
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleComparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis
AuthorsRimei Nishimura, Tomomi Takeshima, Kosuke Iwasaki, Sumiko Aoi
PublishedBMJ Open
Therapeutic AreaType 2 diabetes
TitleAssociation Between HbA1c Levels and Diabetic Peripheral Neuropathy: A Case–Control Study of Patients with Type 2 Diabetes Using Claims Data
AuthorsKazutaka Nozawa, Masato Ikeda, Shogo Kikuchi
PublishedDrugs - Real World Outcomes
Therapeutic AreaType 2 diabetes
TitleReal-world risk of lower-limb amputation associated with sodium–glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in Japan
AuthorsGen Mizutani, Takeshi Horii, Yoichi Oikawa, Koichiro Atsuda, Akira Shimada
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitlePrevalence and predictors of clinical inertia in patients with type 2 diabetes who were treated with a single oral antidiabetic drug
AuthorsRyo Suzuki, Kiyoyasu Kazumori, Tatsuya Usui, Masahiko Shinohara
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleMachine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients
AuthorsEiichiro Kanda, Atsushi Suzuki, Masaki Makino, Hiroo Tsubota, Satomi Kanemata, Koichi Shirakawa & Toshitaka Yajima
PublishedScientific Reports
Therapeutic AreaType 2 diabetes

2021

TitleA Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
AuthorsYoshio Nagai, Kiyoyasu Kazumori, Tomomi Takeshima, Kosuke Iwasaki & Yasushi Tanaka
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleEffects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes
AuthorsYoshio Nagai, Kiyoyasu Kazumori, Tomomi Takeshima, Kosuke Iwasaki & Yasushi Tanaka
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleA Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study
AuthorsShizuka Kaneko, João D. da Rocha Fernandes, Yuiko Yamamoto, Jakob Langer & Mads Faurby
PublishedAdvances in Therapy
Therapeutic AreaType 2 diabetes
TitleLower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases
AuthorsIssei Komuro, Takashi Kadowaki, Johan Bodegård, Marcus Thuresson, Suguru Okami, Toshitaka Yajima
PublishedDiabetes, Obesity and Metabolism
Therapeutic AreaType 2 diabetes
TitleHealthcare resource utilization after initiation of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors or other glucose-lowering drugs in Japanese patients with type 2 diabetes
AuthorsShun Kohsaka, Masayoshi Takeda, Yoko Kidani, Toshitaka Yajima
PublishedDiabetes, Obesity and Metabolism
Therapeutic AreaType 2 diabetes
TitleAcute kidney injury in Japanese type 2 diabetes patients receiving sodium–glucose cotransporter 2 inhibitors: A nationwide cohort study
AuthorsTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, Akira Shimada, Koichiro Atsuda
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleHealthcare resource utilization in patients treated with empagliflozin in East Asia
AuthorsWayne H-H Sheu, Yutaka Seino, Elise Chia-Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook-Jin Chung, Koichi Node, Atsutaka Yasui, Wei-Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz-Luyet, Moe H Kyaw, Dae Jung Kim
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes
TitleAssociation Between the Use of Sodium-Glucose Cotransporter-2 Inhibitors and Drug-Induced Acute Kidney Injury: Analysis of 2 Databases
AuthorsMitsuboshi Satoru, Ryohei Kaseda, Ichiei Narita
PublishedNational Library of Medicine
Therapeutic AreaType 2 diabetes
TitleAssociation between the use of sodium-glucose co-transporter-2 inhibitors and drug-induced acute kidney injury: analysis of two databases
AuthorsMitsuboshi Satoru, Ryohei Kaseda, Ichiei Narita
PublishedThe Journal of Clinical Pharmacology
Therapeutic AreaType 2 diabetes

2020

TitleCost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial
AuthorsHirotaka Watada, Hiroyuki Sakamaki, Daisuke Yabe, Fumiko Yamamoto, Tatsunori Murata, Keigo Hanada, Tetsuaki Hirase, Tomoo Okamura
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleHeart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
AuthorsKåre I. Birkeland, Johan Bodegard, Jan W. Eriksson, Anna Norhammar, Hermann Haller, Gerard C.M. Linssen, Amitava Banerjee, Marcus Thuresson, Suguru Okami, Elena Garal‐Pantaler, Jetty Overbeek, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki
PublishedDiabetes, Obesity and Metabolism
Therapeutic AreaType 2 diabetes
TitleReal-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study
AuthorsTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, Akira Shimada, Koichiro Atsuda
PublishedBMJ Open Diabetes Research & Care
Therapeutic AreaType 2 diabetes

2019

TitleIdentification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium‐glucose co‐transporter‐2 inhibitors with those receiving dipeptidyl peptidase‐4 inhibitors, using a supervised machine‐learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database
AuthorsFang Liz Zhou, Hirotaka Watada, Yuki Tajima, Mathilde Berthelot, Dian Kang, Cyril Esnault, Yujin Shuto, Hiroshi Maegawa, Daisuke Koya
PublishedDiabetes, Obesity and Metabolism
Therapeutic AreaType 2 diabetes
TitleComparison of persistence and adherence between fixed-dose combinations and two-pill combinations in Japanese patients with type 2 diabetes
AuthorsRimei Nishimura, Haruka Kato, Koichi Kisanuki, Akinori Oh, Yoshie Onishi, Florent Guelfucci & Yukio Shimasaki
PublishedCurrent Medical Research and Opinion
Therapeutic AreaType 2 diabetes
TitleTreatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
AuthorsRimei Nishimura, Haruka Kato, Koichi Kisanuki, Akinori Oh, Shinzo Hiroi, Yoshie Onishi, Florent Guelfucci, Yukio Shimasaki
PublishedBMJ Journals
Therapeutic AreaType 2 diabetes
TitleDrug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014–2017)
AuthorsYuichiro Ito, James Van Schyndle, Takuya Nishimura, Toshifumi Sugitani, Tomomi Kimura
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleReal-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus
AuthorsYuichiro Ito, James Van Schyndle, Takuya Nishimura, Toshifumi Sugitani, Tomomi Kimura
PublishedDiabetes Therapy
Therapeutic AreaType 2 diabetes
TitleCost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian population in the EMPA-REG OUTCOME Trial
AuthorsKohei Kaku, Masakazu Haneda, Hiroyuki Sakamaki, AtsutakaYasui, Tatsunori Murata, Anastasia Ustyugova, Rina Chin, Tetsuaki Hirase, Tsunehisa Shibahara, Naoyuki Hayashi, Anuraag Kansal, Stefan Kaspers, Tomoo Okamura
PublishedClinical Therapeutics
Therapeutic AreaType 2 diabetes
TitleIncidence and causes of mildly to moderately elevated aminotransferase in Japanese patients with type 2 diabetes
AuthorsChia-Hsien Chang, Motonobu Sakaguchi
PublishedDiabetology International
Therapeutic AreaType 2 diabetes
TitleTreatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trial
AuthorsShu Meguro, Shingo Matsui & Hiroshi Itoh
PublishedCurrent Medical Research and Opinion
Therapeutic AreaType 2 diabetes
TitleComparison of persistence and adherence between DPP-4 inhibitor administration frequencies in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
AuthorsAkinori Oh, Koichi Kisanuki, Nobuhiro Nishigaki, Yukio Shimasaki, Kazuhiko Sakaguchi & Takeshi Morimoto
PublishedCurrent Medical Research and Opinion
Therapeutic AreaType 2 diabetes
TitleTreatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database
AuthorsYohei Morita, Hiroki Murayama, Masato Odawara, Melissa Bauer
PublishedDiabetology & Metabolic Syndrome
Therapeutic AreaType 2 diabetes

2018

Title日本人の2 型糖尿病患者におけるメトホルミン服用者へのDPP‒4阻害薬追加投与およびメトホルミンの増量の実臨床における有効性―医療情報データベースを用いた検討―
Authors西村 理明, 加藤 晴香, 木佐貫 幸一, 黄 章徳, 大西 佳恵, 西垣 信裕, 嶋﨑 幸生
PublishedTherapeutic Research
Therapeutic AreaType 2 diabetes
Title日本人の2 型糖尿病患者におけるDPP‒4 阻害薬服用者へのメトホルミン追加投与の実臨床における有効性―医療情報データベースを用いた検討―
Authors西村 理明,加藤 晴香,木佐貫 幸一,黄 章徳,大西 佳恵,西垣 信裕,嶋崎 幸生
PublishedTherapeutic Research
Therapeutic AreaType 2 diabetes
TitlePersistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis
AuthorsTakashi Kadowaki, Nobuaki Sarai, Takeshi Hirakawa, Kentaro Taki, Kosuke Iwasaki, Hisashi Urushihara
PublishedDIABETES, OBESITY AND METABOLISM
Therapeutic AreaType 2 diabetes
TitleDipeptidyl Peptidase—4 阻害薬を投与している2 型糖尿病患者へのSodium—glucose Co—transporter2 阻害薬の追加とビグアナイド薬の追加に関する医療情報データベースを用いた比較検討
Authors石井 学, 飯田 光剛, 上野 誠, 奥村 文和, 佐々木 一代, 松川 美幸
Published薬理と治療
Therapeutic AreaType 2 diabetes

2017

TitleIncidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: Retrospective Diagnosis Procedure Combination database analysis
AuthorsYuika Ikeda, Takekazu Kubo, Eisei Oda, Machiko Abe, Shigeru Tokita
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes

2016

TitleEpidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan
AuthorsChia-Hsien Chang, Motonobu Sakaguchi, and Paul Dolin
PublishedPharmacoepidemiology and Drug Safety
Therapeutic AreaType 2 diabetes
TitleUtilization patterns of insulin therapy and healthcare services among Japanese insulin initiators during their first year: a descriptive analysis of administrative hospital data
AuthorsShunya Ikeda, Bruce Crawford, Masayo Sato
PublishedBMC Health Services Research
Therapeutic AreaType 2 diabetes
TitleFracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database
AuthorsMasayo Sato, Wenyu Ye, Tomoko Sugihara, Yoshitaka Isaka
PublishedBMC Musculoskeletal Disorders
Therapeutic AreaType 2 diabetes
TitlePrescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database
AuthorsMakito Tanabe, Ryoko Motonaga, Yuichi Terawaki, Takashi Nomiyama, Toshihiko Yanase
PublishedJournal of Diabetes Investigation
Therapeutic AreaType 2 diabetes

2015

TitleReduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database
AuthorsMakito Tanabe, Takashi Nomiyama, Ryoko Motonaga, Kunitaka Murase, Toshihiko Yanase
PublishedBMC Endocrine Disorders 2015
Therapeutic AreaType 2 diabetes
TitleImpact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients
AuthorsTadaaki Hanatani, Kimie Sai, MasahiroTohkin, Katsunori Segawa, Yoshiro Saito
PublishedInternational Journal of Clinical Pharmacy
Therapeutic AreaType 2 diabetes

2012

TitleIncreased Risk of Acute Pancreatitis in Patients with Type 2 Diabetes: An Observational Study Using a Japanese Hospital Database
AuthorsHisashi Urushihara, Masanori Taketsuna, Ying Liu, Eisei Oda, Masaki Nakamura, Shinichi Nishiuma, Rei Maeda
PublishedPLOS ONE
Therapeutic AreaType 2 diabetes

2011

Title多施設医事会計データのレトロスペクティブ解析による経口糖尿病治療薬グリメピリドのジェネリック医薬品に関する臨床的有用性の検討
Authors柳瀬 敏彦,竹之下 博正,村瀬 邦崇,永石 綾子,野見山 崇,明比 祐子 (福岡大学医学部)
Published月刊内分泌・糖尿病・代謝内科
Therapeutic AreaType 2 diabetes

About Japanese Healthcare System

What you need to know about the healthcare system in Japan before using the data.

SERVICE

In addition to various web tools that allow you to easily conduct surveys via a browser using our medical database, we offer data provision services categorized into four types to meet your needs and challenges: "Analysis reports" "Datasets," "All Therapeutic Areas Data Provision Service," and "Specific Therapeutic Areas Data Provision Service.

page top